Monopar Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$8,402,196 over the previous period. Total operating expenses were $8,831,235.
Profit Margin
| 2015 | 0 | -687.31K | |
|---|---|---|---|
| 2016 | 0 | -1.18M | |
| 2017 | 0 | -16.55M | |
| 2018 | 0 | -3.22M | |
| 2019 | 0 | -4.12M | |
| 2020 | 0 | -6.22M | |
| 2021 | 0 | -9.07M | |
| 2022 | 0 | -10.49M | |
| 2023 | 0 | -8.40M |
MNPR Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||||||
Research and development | 5.60M | 7.59M | 6.49M | 4.06M | 1.96M | 1.77M | 15.43M | 280.35K | 101.48K |
Selling and marketing | -3.22B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 8.83M | 10.53M | 9.12M | 6.50M | 4.32M | 3.40M | 16.60M | 1.19M | 688.56K |
Operating income | -8.83M | -10.53M | -9.12M | -6.50M | -4.32M | -3.40M | -16.60M | -1.19M | -688.56K |
Other income (expenses), net | 429.03K | 21.23K | 24.02K | 204.30K | 98.88K | 103.21K | 48.25K | 7.23K | 1.24K |
Income before tax | -8.40M | -10.51M | -9.10M | -6.30M | -4.22M | -3.29M | -16.55M | -1.18M | -687.31K |
Income tax expense | 0 | -21.23K | -24.02K | -81.90K | -98.88K | -71.61K | -2.10M | 0 | -688.56K |
Net income | -8.40M | -10.49M | -9.07M | -6.22M | -4.12M | -3.22M | -16.55M | -1.18M | -687.31K |
Earnings per share | |||||||||
Basic EPS | -0.58 | -0.83 | -0.73 | -0.57 | -0.39 | -0.31 | -1.59 | -0.11 | -0.06 |
Diluted EPS | -0.58 | -0.83 | -0.73 | -0.57 | -0.39 | -0.31 | -1.59 | -0.11 | -0.06 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |